NEOGEN CLO Acquires Shares via RSU Vesting
NEOGEN CORP
Subscribe to track NEOG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
NEOGEN CLO Acquires Shares via RSU Vesting
Company: NEOGEN CORP (NEOG) Form: 4 | Filed: 2025-10-14 Significance: Low
Insider: Rocklin Amy M Title: Chief Legal Officer | Relationship: Officer
Transaction: • Type: RSU Vesting & Tax Withholding • Acquired: 294 shares @ $6.04 • Disposed (Taxes): 115 shares @ $6.04 • Net Value: $1,081.16 • Owned After: 49,851 shares
Key Insight: This is a routine, non-discretionary transaction related to executive compensation (vesting of Restricted Stock Units) and not an open-market trade. The low dollar value and compensatory nature indicate low trading significance.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: NEOGEN CORP (NEOG)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Legal Officer acquired a small number of shares through the vesting of Restricted Stock Units (RSUs), with a portion automatically sold to cover taxes. This is a routine compensatory event, not a discretionary insider trade, and carries minimal market signaling value.
- Market Impact: Neutral. The transaction is too small and of a non-discretionary nature to impact market sentiment or stock price.
Company Information
| Field | Value |
|---|---|
| Company | NEOGEN CORP |
| Ticker Symbol | NEOG |
| CIK | 0000711377 |
| Industry | In Vitro & In Vivo Diagnostic Substances [2835] |
Insider Information
| Field | Value |
|---|---|
| Name | Rocklin Amy M |
| CIK | 0001959089 |
| Title/Position | Chief Legal Officer |
| Relationship | Officer |
Transaction Details
This filing reports two related non-derivative transactions occurring on the same day.
Transaction 1: RSU Vesting (Acquisition)
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-13 |
| Transaction Code | M (Exercise/Conversion of derivative security) |
| Security Type | Common Stock |
| Shares Involved | 294 |
| Price Per Share | $6.04 |
| Total Value | $1,775.76 |
| Acquired/Disposed | A (Acquired) |
| Ownership Type | Direct |
Transaction 2: Tax Withholding (Disposition)
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-13 |
| Transaction Code | F (Payment of tax liability by withholding securities) |
| Security Type | Common Stock |
| Shares Involved | 115 |
| Price Per Share | $6.04 |
| Total Value | $694.60 |
| Acquired/Disposed | D (Disposed) |
| Ownership Type | Direct |
Net Result: The insider had a net acquisition of 179 shares (294 acquired - 115 disposed) and the final ownership stands at 49,851 shares.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transactions are part of a pre-scheduled executive compensation plan (RSU vesting). The disposition (Code 'F') is an automatic sale to cover tax obligations and does not reflect a negative sentiment from the insider. The total value is negligible.
Volume & Sentiment
- Expected Volume Impact: None. The transaction size is too small to have a noticeable effect on trading volume.
- Sentiment Indicator: Neutral. Compensatory transactions like this are common and do not provide insight into an insider's current view of the company's future prospects.
Investment Insights
Positive Market Indicators
- The vesting of equity awards aligns the insider's interests with those of shareholders over the long term.
Risk Factors
- No new risk factors are indicated by this filing. It is a routine administrative transaction.
Key Takeaways
- Compensatory Event: This is not an open-market buy or sell. It is the settlement of vested RSUs, a standard part of executive pay.
- Tax Withholding: The sale of 115 shares was to cover tax liabilities associated with the vesting, a common and non-discretionary practice known as a 'sell-to-cover'.
- Low Significance: Due to the small dollar amount and the non-discretionary nature of the event, this filing has low significance for investors.
Contextual Analysis
Timing Significance
- The transaction date corresponds to a vesting schedule milestone for the insider's RSUs. The timing is dictated by the original grant agreement, not by market conditions.
Transaction Context
- The filing includes a derivative transaction showing the disposition of 294 Restricted Stock Units (RSUs) which were converted into an equal number of common stock shares. The 'M' and 'F' codes in the non-derivative table reflect the settlement of these RSUs and the subsequent tax payment.
Company Context
- Analysis of this filing should be done in the context of NEOGEN's recent performance, industry trends in the diagnostic substances sector, and any recent company announcements. However, this specific filing is administrative in nature.
Risk Assessment
Risk Level: Low
Risk Factors
- The filing itself presents no new risks.
- Investors should focus on the company's fundamental business performance, not this routine insider transaction.
Market Considerations
- The market generally ignores small, compensatory insider transactions as they lack predictive value for future stock performance.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-14 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.